BL

Boppa Lakshmi Swetha

Active Director Managing Director DIN 11720852
DIN 11720852 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Boppa Lakshmi Swetha

Data last updated:

Boppa Lakshmi Swetha is a Managing Director at Sri Keyura Pharma Private Limited (since 2026).

DIN 11720852
Primary Designation Managing Director
First Appointment 20 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sri Keyura Pharma Private Limited U21000TS2026PTC216587
Managing Director20 May 20262026Active

Board colleagues of Boppa Lakshmi Swetha

NameDINCompanyDesignation
Bharani Boppa11720274Sri Keyura Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sri Keyura Pharma Private Limited
Premium access

Shareholding and investment profile for Boppa Lakshmi Swetha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Boppa Lakshmi Swetha

Boppa Lakshmi Swetha currently holds 1 directorship: Sri Keyura Pharma Private Limited (Managing Director, since 20 May 2026).

Boppa Lakshmi Swetha was first appointed on 20 May 2026 as Managing Director at Sri Keyura Pharma Private Limited.

The current boards of Boppa Lakshmi Swetha's companies include Bharani Boppa (Sri Keyura Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available